Search Results

46 articles with title/keywords/abstract containing Induced-abortion

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Display per page 

Reduced risk of infection after change in regimen for abortion

Source: Reactions, Volume 1, Number 1261, 2009-07-18 , pp. 1-1(1)

Publisher: Adis International

Warfarin: Fetal subdural haematoma following in utero exposure: case report

Source: Reactions, Volume 1, Number 1244, 2009-03-21 , pp. 45-45(1)

Publisher: Adis International

Misoprostol for second-trimester abortion induction

Source: Inpharma, Volume 1, Number 1624, 2008-02-09 , pp. 19-19(1)

Publisher: Adis International

Misoprostol for incomplete abortion in developing countries

Source: Inpharma, Volume 1, Number 1618, 2007-12-15 , pp. 17-17(1)

Publisher: Adis International

Medical and surgical abortion deliver similar subsequent risk

Source: Inpharma, Volume 1, Number 1602, 2007-08-25 , pp. 10-10(1)

Publisher: Adis International

Sublingual misoprostol compared with vaginal misoprostol for medical abortion

Source: Inpharma, Volume 1, Number 1592, 2007-06-16 , pp. 1-1(1)

Publisher: Adis International

Abortion strategies with mifepristone + misoprostol

Source: Inpharma, Volume 1, Number 1586, 2007-05-05 , pp. 14-14(1)

Publisher: Adis International

IV fentanyl + midazolam superior for reducing intraop pain

Source: Inpharma, Volume 1, Number 1566, 2006-12-02 , pp. 16-16(1)

Publisher: Adis International

Mifeprex: two additional sepsis deaths reported to US FDA

Source: Reactions, Volume 1, Number 1094, 2006-03-25 , pp. 2-2(1)

Publisher: Adis International

Mifepristone/misoprostol: Fatal septic shock: case report

Source: Reactions, Volume 1, Number 1089, 2006-02-18 , pp. 20-20(1)

Publisher: Adis International

Fatal sepsis with mifepristone, but no need to abort the drug

Source: Reactions, Volume 1, Number 1081, 2005-12-10 , pp. 2-2(1)

Publisher: Adis International

Fatal sepsis with mifepristone, but no need to abort the drug

Source: Inpharma, Volume 1, Number 1517, 2005-12-10 , pp. 3-3(1)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A